ANRO
Alto Neuroscience, Inc.
23.50$
-0.7%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +46.0% | +5.4% | +16.5% | +19.5% | +25.9% | +0.6% | -1.2% | -3.0% | -4.3% | +17.2% | +0.0% | – | |
| – | +12.0% | +259.6% | -13.4% | +5.8% | -21.6% | +25.7% | +1.9% | +9.2% | -11.1% | +45.1% | +25.8% | – | |
| – | -238.6% | – | – | +94.8% | -96.4% | -4,806.1% | – | +0.2% | +61.9% | -309.2% | – | – | |
| – | +718.6% | -36.4% | +51.8% | +195.6% | -49.7% | -95.3% | -100.0% | – | – | – | -100.0% | – | |
| – | +718.6% | -36.4% | +51.8% | +195.6% | -49.7% | -95.3% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | +2,819.2% | – | – | |
| – | – | – | – | – | – | – | -100.0% | – | – | – | – | – | |
| – | +87,924.5% | +212.0% | -100.2% | – | -96.3% | +18,526.5% | -93.3% | -75.0% | +32,700.7% | +129.0% | -100.2% | – | |
| – | – | +294.6% | -109.9% | – | – | – | – | – | – | +125.7% | -122.9% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.